E-LIB Suche - Ergebnisse für: Foley, Stephen Ronan

1

Durable Efficacy and Manageable Safety in Patients Age ≥75 ..:

Landsburg, Daniel J. ; Heim, Michael ; Moskop, Amy...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S187-S188 , 2024

Link: https://doi.org/10.1016/..

2

Real-World Tisagenlecleucel Outcomes in Richter-Transformed..:

Shadman, Mazyar ; Frigault, Matthew J. ; Foley, Stephen Ronan...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S189-S190 , 2024

Link: https://doi.org/10.1016/..

3

Tisagenlecleucel immunogenicity in relapsed/refractory acut..:

Thudium Mueller, Karen ; Grupp, Stephan A. ; Maude, Shannon L....
Blood Advances. 5 (2021) 23 - p. 4980-4991 , 2021

Link: https://doi.org/10.1182/..

4

Tisagenlecleucel cellular kinetics, dose, and immunogenicit..:

Awasthi, Rakesh ; Pacaud, Lida ; Waldron, Edward...
Blood Advances. 4 (2020) 3 - p. 560-572 , 2020

Link: https://doi.org/10.1182/..

5

Long-Term Follow-up of Tisagenlecleucel in Adult Patients w..:

Schuster, Stephen J. ; Bishop, Michael R. ; Tam, Constantine S....
Biology of Blood and Marrow Transplantation. 25 (2019) 3 - p. S20-S21 , 2019

Link: https://doi.org/10.1016/..

6

Prolonged Improvement in Patient Reported Quality of Life (..:

Tam, Constantine S. ; Waller, Edmund K. ; Jaeger, Ulrich...
Biology of Blood and Marrow Transplantation. 25 (2019) 3 - p. S181-S182 , 2019

Link: https://doi.org/10.1016/..

7

Study Design of a Phase 3, Randomized, Open-Label, Multicen..:

Zeiser, Robert ; Ram, Ron ; Foley, Stephen Ronan...
Biology of Blood and Marrow Transplantation. 24 (2018) 3 - p. S208 , 2018

Link: https://doi.org/10.1016/..

8

Global Pivotal Phase 2 Trial of the CD19-Targeted Therapy C..:

Schuster, Stephen ; Bishop, Michael R. ; Tam, Constantine...
Clinical Lymphoma Myeloma and Leukemia. 17 (2017) - p. S373-S374 , 2017

Link: https://doi.org/10.1016/..

9

Characterizing Complex Polysera Produced by Antigen-Specifi..:

Denisova, Galina ; Denisov, Dimitri ; Evelegh, Carole...
PLoS ONE. 4 (2009) 4 - p. e5309 , 2009

Link: https://doi.org/10.1371/..

10

Tisagenlecleucel immunogenicity in relapsed/refractory acut..:

Thudium Mueller, Karen ; Grupp, Stephan A ; Maude, Shannon L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153050/. , 2021

Link: http://www.ncbi.nlm.nih...

11

Tisagenlecleucel cellular kinetics, dose, and immunogenicit..:

Awasthi, Rakesh ; Pacaud, Lida ; Waldron, Edward...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013261/. , 2020

Link: http://www.ncbi.nlm.nih...

12

Long-term safety for patients with tisagenlecleucel-treated..:

Jaeger, Ulrich ; Tam, Constantine S. ; Borchmann, Peter...
Blood Advances. , 2022

Link: https://doi.org/10.1182/..

13

Correlative Analyses of Cytokine Release Syndrome and Neuro..:

Bachanova, Veronika ; Westin, Jason ; Tam, Constantine...
Clinical Lymphoma Myeloma and Leukemia. 19 (2019) - p. S251-S252 , 2019

Link: https://doi.org/10.1016/..

14

Lentivirus-mediated gene therapy for Fabry disease:

Khan, Aneal ; Barber, Dwayne L. ; Huang, Ju...
Nature Communications. 12 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

15

Higher levels of free plasma mitochondrial DNA are associat..:

Rozmus, Jacob ; Ivison, Sabine ; Kariminia, Amina...
Bone Marrow Transplantation. 53 (2018) 10 - p. 1263-1269 , 2018

Link: https://doi.org/10.1038/..